EACH/PIC Coalition

About the Coalition

The Ensuring Access through Collaborative Health (EACH) and Patient Inclusion Council (PIC) is a two-part coalition that unites patient organizations and allied groups (EACH), as well as patients and caregivers (PIC), to advocate for drug affordability policies that benefit patients. Our focus is on state level Prescription Drug Affordability Boards (PDABs) and the Centers for Medicare and Medicaid Services (CMS) Inflation Reduction Act (IRA) drug price negotiations.

Putting Patients First

Advocating for Healthcare Policies that Prioritize Patient Perspectives

  • Unite national and state patient organizations and allied groups (EACH) and patients and caregivers (PIC) to advocate for treatment affordability policies that consider patient needs first.
  • Educate stakeholders on drug affordability reviews and opportunities to participate in the process.
  • Facilitate collaboration between decision-makers and coalition members to form alliances and improve outcomes.

Working Principles

Patient Voices Must Be Involved in Policies Addressing Treatment Affordability Challenges

Lived experience is foundational to identifying affordability challenges and, in turn, making effective health policy decisions. Therefore, it is critical that any health policy discussion or associated process include patient and caregiver perspectives, as well as patient organizations who have an understanding of the life cycle of disease from the lens of prevention, diagnosis, and disease management.

Identify and Resolve Patient-Reported Obstacles to Care

Lived experience is foundational to identifying affordability challenges and, in turn, making effective health policy decisions. Therefore, it is critical that any health policy discussion or associated process include patient and caregiver perspectives, as well as patient organizations who have an understanding of the life cycle of disease from the lens of prevention, diagnosis, and disease management.

Protect Patient Access, Recognizing Potential for Costly Tradeoffs

PDABs and regulators should use their mandate to engage stakeholders and fully examine ways that setting prices or upper payment limits could impact patients. Specifically, if measures to limit drug prices are found to decrease access to drugs, limit patient treatment options, or lead to increased utilization management, then they should be rejected. Regulators must work with patients, caregivers, as well as patient organizations and allied groups, to understand the full breadth of issues that could impact their care. Solutions should improve quality of life and reduce costly adverse events, not impose more obstacles to safe and effective drugs that could keep patients healthier and less reliant on other high-cost or emergency care.

Our Team

About the Coalition National Network

The EACH/PIC Coalition, made up of patient organizations, allied groups, patients, and caregivers, aims to be a primary resource of information to help policymakers and advocates alike navigate the government drug affordability review process and address real patient issues.  

We implement a “National Network” philosophy, where participants who are active at state or national levels are encouraged to lead updates and share their resources to increase our impact.

Scroll to Top